Overview

Gender

male

David O’Reilly is an entrepreneur and executive in the life sciences industry with 30 years of experience in founding, financing and growing innovative pharmaceutical, medical device and digital health companies. He is co-founder and Chief Executive Officer of Cavalon Therapeutics, a company developing medicines for neurodegenerative and neuropsychiatric disorders. He is also Managing Director of Bayview Biosciences, a firm that provides advisory, consulting and new company formation services to life sciences organizations. He is a member of the Board of Directors of Baymatob, a company that develops innovative medical devices and predictive algorithms to monitor pregnancy and labor progression. He is also a member of the Board of Trustees of The Health Trust, a nonprofit operating foundation focused on building health equity in Silicon Valley. David also serves on the advisory boards of HealthRhythms, a digital therapeutics company, and Paradromics, a brain-computer interface company. Prior to this, David was Chief Platform Officer and Chief Product Officer of Proteus Digital Health, where he led Proteus’s sensor development, digital medicine formulation, product development, manufacturing operations and corporate development functions. Leading these teams, he negotiated and raised over $400 million in equity investments and strategic partner funding, launched three commercial digital medicine products, manufactured and shipped over 10 million product units annually and generated and managed over $30 million in revenue annually. Prior to Proteus, he was President of Catalyst Biosciences, Chief Business Officer of Iconix Biosciences, Head of Corporate Development at ARIAD Pharmaceuticals and a strategy consultant at L.E.K. Consulting.